
Kenneth T. Lam
Examiner (ID: 17611, Phone: (571)270-1862 , Office: P/2631 )
| Most Active Art Unit | 2631 |
| Art Unit(s) | 2611, 2631 |
| Total Applications | 1175 |
| Issued Applications | 946 |
| Pending Applications | 89 |
| Abandoned Applications | 150 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19196553
[patent_doc_number] => 11993782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Lentivirus packaging system, lentivirus produced by the same, cell transduced by the lentivirus, method for improving lentivirus production in a host cell, and method of using the cell for treating cancer
[patent_app_type] => utility
[patent_app_number] => 17/377830
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 5589
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377830 | Lentivirus packaging system, lentivirus produced by the same, cell transduced by the lentivirus, method for improving lentivirus production in a host cell, and method of using the cell for treating cancer | Jul 15, 2021 | Issued |
Array
(
[id] => 18139897
[patent_doc_number] => 20230013733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => MICROCARRIERS WITH SCAFFOLD STRUCTURE AND CONTINUOUS OUTER WALL FOR CULTURING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/374157
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374157 | MICROCARRIERS WITH SCAFFOLD STRUCTURE AND CONTINUOUS OUTER WALL FOR CULTURING CELLS | Jul 12, 2021 | Abandoned |
Array
(
[id] => 18628478
[patent_doc_number] => 20230287343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO
[patent_app_type] => utility
[patent_app_number] => 18/015489
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015489
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015489 | METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO | Jul 11, 2021 | Pending |
Array
(
[id] => 19280035
[patent_doc_number] => 20240216508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/011780
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 129503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011780
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011780 | ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS | Jun 24, 2021 | Pending |
Array
(
[id] => 17314820
[patent_doc_number] => 20210403868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => DEVICE FOR CELL CULTURE AND CELL CULTURING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/304687
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304687 | DEVICE FOR CELL CULTURE AND CELL CULTURING METHOD | Jun 23, 2021 | Abandoned |
Array
(
[id] => 18530218
[patent_doc_number] => 20230235288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => PERIPHERAL BLOOD DERIVED SMALL PLURIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 18/002151
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002151
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002151 | PERIPHERAL BLOOD DERIVED SMALL PLURIPOTENT CELLS | Jun 20, 2021 | Pending |
Array
(
[id] => 19359367
[patent_doc_number] => 20240261401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => ENGINEERED IMMUNE CELLS, COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/928414
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/928414 | ENGINEERED IMMUNE CELLS, COMPOSITIONS AND METHODS THEREOF | May 25, 2021 | Abandoned |
Array
(
[id] => 17314480
[patent_doc_number] => 20210403528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Novel T-Cell Receptor and Ligand
[patent_app_type] => utility
[patent_app_number] => 17/326661
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/326661 | Novel T-Cell Receptor and Ligand | May 20, 2021 | Abandoned |
Array
(
[id] => 17228888
[patent_doc_number] => 20210355444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => METHOD FOR PRODUCING ERYTHROID CELLS AND/OR ERYTHROCYTES
[patent_app_type] => utility
[patent_app_number] => 17/319871
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319871
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319871 | METHOD FOR PRODUCING ERYTHROID CELLS AND/OR ERYTHROCYTES | May 12, 2021 | Abandoned |
Array
(
[id] => 18418529
[patent_doc_number] => 20230172987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/997731
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 208596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -379
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997731 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY | May 3, 2021 | Pending |
Array
(
[id] => 17183875
[patent_doc_number] => 20210330760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHODS AND MATERIALS FOR TREATING OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/236726
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236726 | METHODS AND MATERIALS FOR TREATING OSTEOARTHRITIS | Apr 20, 2021 | Abandoned |
Array
(
[id] => 18451925
[patent_doc_number] => 20230193204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/996033
[patent_app_country] => US
[patent_app_date] => 2021-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -132
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996033 | TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATION | Apr 9, 2021 | Pending |
Array
(
[id] => 17140175
[patent_doc_number] => 20210308186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Treatment of Acute Respiratory Distress Syndrome by T Regulatory Cells
[patent_app_type] => utility
[patent_app_number] => 17/224909
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/224909 | Treatment of Acute Respiratory Distress Syndrome by T Regulatory Cells | Apr 6, 2021 | Abandoned |
Array
(
[id] => 18376012
[patent_doc_number] => 20230151094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => CHIMERIC ANTIGEN RECEPTORS TARGETING CD33
[patent_app_type] => utility
[patent_app_number] => 17/995085
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995085
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995085 | CHIMERIC ANTIGEN RECEPTORS TARGETING CD33 | Mar 30, 2021 | Pending |
Array
(
[id] => 18754314
[patent_doc_number] => 20230357711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => CELL SUPPORT AND METHOD OF PRODUCING SAME, CELL CULTURE METHOD AND CELL STRUCTURE
[patent_app_type] => utility
[patent_app_number] => 18/026474
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026474 | CELL SUPPORT AND METHOD OF PRODUCING SAME, CELL CULTURE METHOD AND CELL STRUCTURE | Mar 22, 2021 | Pending |
Array
(
[id] => 18323305
[patent_doc_number] => 20230121433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => CHIMERIC STIMULATORY RECEPTORS AND METHODS OF USE IN T CELL ACTIVATION AND DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 17/906034
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906034 | CHIMERIC STIMULATORY RECEPTORS AND METHODS OF USE IN T CELL ACTIVATION AND DIFFERENTIATION | Mar 10, 2021 | Pending |
Array
(
[id] => 18312183
[patent_doc_number] => 20230116083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => UP-SCALED PRODUCTION OF MICROGLIA-LIKE/-PRECURSOR CELLS AND MACROPHAGE CELLS USING MESH MACROCARRIERS
[patent_app_type] => utility
[patent_app_number] => 17/908857
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908857 | UP-SCALED PRODUCTION OF MICROGLIA-LIKE/-PRECURSOR CELLS AND MACROPHAGE CELLS USING MESH MACROCARRIERS | Mar 9, 2021 | Pending |
Array
(
[id] => 18420486
[patent_doc_number] => 20230174948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => METHOD OF GENERATING ENDOTHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 17/905691
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905691 | METHOD OF GENERATING ENDOTHELIAL CELLS | Mar 4, 2021 | Pending |
Array
(
[id] => 16930881
[patent_doc_number] => 20210196770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => PLATFORM ONCOLYTIC VECTOR FOR SYSTEMIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/192736
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/192736 | PLATFORM ONCOLYTIC VECTOR FOR SYSTEMIC DELIVERY | Mar 3, 2021 | Pending |
Array
(
[id] => 18649755
[patent_doc_number] => 20230295575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => METHODS OF INCREASING MATURATION OF HEART, PANCREATIC BETA-CELLS, AND NEURONS
[patent_app_type] => utility
[patent_app_number] => 17/760378
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760378 | METHODS OF INCREASING MATURATION OF HEART, PANCREATIC BETA-CELLS, AND NEURONS | Feb 8, 2021 | Abandoned |